2-year Caries Clinical Study: Arginine Fluoride-Free Toothpastes vs. NaF Toothpaste
Study Details
Study Description
Brief Summary
The objective of this study is to evaluate the anticaries efficacy for three dentifrices (1.5% arginine in a calcium base, 8.0% arginine in a calcium base, and 0.32% sodium fluoride in a silica base) in a two-year caries clinical study
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Phase 3 |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Active Comparator: 0.32% Sodium Fluoride Dentifrice Toothpaste Whole mouth brushing with a toothpaste, 2 times/day for 2 minutes each time for the duration of the study |
Drug: 0.32% Sodium Fluoride Dentifrice Toothpaste
Toothpaste
|
Experimental: 1.5% Arginine Dentifrice Toothpaste Whole mouth brushing with a toothpaste, 2 times/day for 2 minutes each time for the duration of the study |
Drug: 1.5% Arginine Dentifrice
Toothpaste
|
Experimental: 8.0% Arginine Dentifrice Toothpaste Whole mouth brushing with a toothpaste, 2 times/day for 2 minutes each time for the duration of the study |
Drug: 8.0% Arginine Dentifrice
Toothpaste
|
Outcome Measures
Primary Outcome Measures
- The primary efficacy endpoint will be the incremental subject-wise Decayed Missing Filled Surfaces score after 2 year product use. [2 year]
the minimum score is 0, maximum score is 4/5 depending on the tooth number and a higher score represents a worse outcome
- The primary efficacy endpoint will be the incremental subject-wise Decayed Missing Filled Teeth scores after two year of product use. [2 year]
the minimum score is 0, maximum score is 4/5 depending on the tooth number and a higher score represents a worse outcome
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Informed Consent Form signed by parent or legal guardian to permit participation of their child in the study
-
Willingness and ability to use the assigned products according to instructions, availability for all appointments and likelihood of completing the clinical trial.
-
Children ages 10-14 years at baseline.
-
Presence of second molars or evidence of erupting permanent molars.
-
Subjects should be of good general health as evidenced by a review of the medical history.
-
Presence of two or more active caries lesions (ICDAS scores of 2 or greater) and with a previous caries experience (DMFS ≥ 2). Exclusion Characteristics
-
Subjects presenting with any of the criteria below will be excluded from the study:
-
Presence of fixed or removable prosthetic appliance or orthodontic treatment involving more than four permanent teeth.
-
Use of medication that could increase the risk of developing dental caries, i.e. medication that reduces saliva flow.
-
Long-term antibiotic therapy.
-
Children with cognitive and/or motor impairment.
-
Severe malocclusion.
-
Presence of severe caries (ICDAS 5 or 6) on five or more teeth.
-
Evidence of moderate to severe periodontal disease.
-
Participation in any other clinical study within the 30 days preceding the clinical study.
-
History of allergies or other adverse reactions to arginine, or oral care products, or their ingredients.
-
Pregnant or lactating.
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | School of Stomatology, Xian Jiaotong University | Xi'an | Shaanxi | China | 710004 |
2 | West China School of Stomatology, Sichuan University | Chengdu | Sichuan | China | 610041 |
3 | School of Stomatology Chongqing Medical University | Chongqing | China | 400016 |
Sponsors and Collaborators
- Colgate Palmolive
Investigators
- Study Director: Yun Po E Zhang, PhD, DDS(Hons), Colgate Palmolive
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- CRO-2018-12-CAR-ARG-YPZ